Clinical Trials · NCT02960022
A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
- Phase
- Phase 2
- Recruitment status
- Recruiting
- Sponsor
- Astellas Pharma Global Development, Inc.
- Enrollment
- 900
- Start date
- Dec 2016
- Locations
- 241 sites, 38 countries
- Primary endpoint
- Number of participants with adverse events